Publication | Closed Access

Posttreatment with EPC-K1, an inhibitor of lipid peroxidation and of phospholipase A2 activity, reduces functional deficits after global ischemia in rats

InflammationMetabolic SyndromeOxysterolBiochemistryGlobal IschemiaMedicineLipid PeroxidationPhysiologyCell DeathVascular BiologyReperfusion InjuryPharmacologyAtherosclerosisFunctional DeficitsIschemic SyndromeOxidative StressHealth Sciences